1. Switzerland Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
Straumann Holding AG

Straumann Holding AG

STMN.SW
Straumann Holding AGCH flagSwiss Exchange
93.84
CHF
-0.40
- -
14.96BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Revenue per Share
4.4
4.57
5.1
5.87
7.18
8.62
10.07
8.98
12.71
14.57
14.28
- -
- -
Basic EPS, GAAP
0.65
1.01
0.45
1.47
1.8
1.72
1.93
0.57
2.49
2.73
1.54
- -
- -
Free Cash Flow per Basic Share
0.9
0.82
0.96
0.88
0.93
1.06
1.44
1.85
2.76
1.38
1.99
- -
- -
Dividend per Share
0.37
0.37
0.37
0.4
0.42
0.47
0.52
0.57
0.57
0.67
0.8
- -
- -
Book Value per Share
4.08
4.74
3.86
4.05
6.95
7.59
8.6
7.59
9.4
11.62
11.52
- -
- -
Tangible Book Value per Share
3.62
4.29
2.29
2.04
2.77
3.49
3.94
3.52
5.42
6.75
5.84
- -
- -
Basic Weighted Avg Shares
155
156
157
156
155
158
159
159
159
159
159
- -
- -
Sales/Revenue/Turnover
680
710
799
918
1,112
1,364
1,596
1,426
2,022
2,321
2,277
2,504
2,605
Operating Margin (%)
16.62
20.57
21.34
24.5
25.17
24.88
23.45
10.64
26.53
23.07
26.27
24
21.08
Depreciation Expense
32
28
35
32
40
52
93
99
103
163
123
145
158
Net Income, GAAP
101
158
71
230
280
273
306
91
396
435
246
388
356
Effective Tax Rate (%)
15.59
11.05
10.83
- -
12.65
14.9
15.72
19
16.36
12.77
17.98
17.89
21.33
Profit Margin (%)
14.88
22.22
8.85
25.02
25.14
20
19.2
6.4
19.59
18.73
10.81
15.51
13.66
Working Capital
443
526
386
289
471
491
303
773
966
621
676
579
903
LT Debt
199
199
200
200
201
201
232
696
681
395
383
185
397
Total Equity
631
737
605
634
1,077
1,204
1,367
1,210
1,500
1,854
1,839
2,044
2,165
Return on Invested Capital (%)
13.08
14.42
17.02
- -
22.48
20.77
18.75
6.31
20.9
18.76
19.47
20.09
16.61
Return on Capital (%)
14.57
18.3
8.48
- -
26.71
20.5
19.81
5.48
19.67
18.89
10.72
15.38
11.62
Return on Common Equity (%)
16.41
23.07
10.53
37.07
32.68
23.95
23.9
7.11
29.34
25.98
13.35
17.55
13.02

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
15.24%
12.76%
5.92%
Free Cash Flow
10.96%
6.37%
-11.12%
Net Income, GAAP
53.61%
69.95%
-8.34%
Sales/Revenue/Turnover
13.38%
13.74%
4.05%
Total Cash Common Dividend
10.11%
10.87%
11.75%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
2,277
2024
- -
- -
- -
- -
2,504
2025
- -
- -
- -
- -
2,605

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
1.54
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.8
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Guillaume Daniellot
Full Time Employees
11,342
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Address
Peter Merian-Weg 12 Basel Switzerland 4002
IPO Date
Jul 17, 1998
Website
straumann.com
Similar Companies
Bausch + Lomb Corporation (BLCO.TO)
Visco Vision Inc. (6782.TW)
Carl Zeiss Meditec AG (CZMWY)
Medeon Biodesign, Inc. (6499.TWO)
Kawamoto Corporation (3604.T)
Kelfred Holdings Limited (1134.HK)
Business
Straumann Holding AG manufactures and distributes dental implants, prosthetic solutions, regenerative biomaterials, orthodontic aligners and digital dentistry equipment worldwide. The company offers premium implant systems including Roxolid titanium-zirconium alloy, SLActive surface technology and iEXCEL high-performance implants; prosthetic components such as abutments, crowns and bridges utilizing CAD/CAM processes; regenerative products for tissue and bone regeneration; ClearCorrect clear aligners for orthodontics; and digital tools encompassing SIRIOS intraoral scanners, MIDAS 3D printers, milling machines and the Straumann AXS cloud-based workflow platform; challenger brands like Neodent implants and Anthogyr solutions complement the portfolio. Straumann Holding AG, founded in 1954 and headquartered in Basel, Switzerland, operates manufacturing facilities in Switzerland, the United States, Germany, China and Brazil, with sales in more than 100 countries across EMEA, North America, Asia-Pacific and Latin America through subsidiaries, distributors and dental laboratories. Recent developments include the full acquisition of maxon dental GmbH to bolster ceramic implant capabilities; strategic partnerships with Smartee for scalable clear aligner production and DentalMonitoring for remote orthodontic monitoring to transform the orthodontics segment; launches of the SIRIOS X3 mid-price intraoral scanner and MIDAS chairside 3D printer integrated into the AXS ecosystem; and inauguration of the Shanghai manufacturing campus supporting localized production ahead of China's VBP 2.0 procurement cycle.